AvantiCell Science Ltd
- Country
- United Kingdom
- Type
- Beneficiary
- Website
- www.avanticell.com
- Grants received
- 13
Funding record
- 13 grants on record
- €5,598,466.05 awarded in total
- 2008–2018 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
7 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
- EXPLORA SRL
- FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA
- IDRYMA TECHNOLOGIAS KAI EREVNAS
- KAROLINSKA INSTITUTET
- PARIS-LODRON-UNIVERSITAT SALZBURG
- RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- THE UNIVERSITY OF EDINBURGH
Calls from this organisation
No published calls from this organisation.
Grants received
- A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation
- TRANSlating the role of Mitochondria in Tumorigenesis
- Cell-Based Models for Neurodegeneration Study and Use in Screening
- Probing safety of nano-objects by defining immune responses of environmental organisms
- Additive Printing for Cell-Based Analysis
- Chromatin Dynamics in Development and Disease
- Additive Printing for Cell-based Analysis
- Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers
- Nano Engineering for Cross Tolerance: new approach for bioengineered, vascularised, chimeric islet transplantation in non-immunosuppressed hosts
- Cell-Based Models of Human Mucosal Immunity with Multiple Commercial Applications
- A bioartificial pancreas to treat type 1 diabetes: optimization of cell survival and function in preclinical and clinical phases
- Nanotechnology: Training Of Experts in Safety
- Magnetic Scaffolds for in vivo Tissue Engineering
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.